Leuprolide and dyspnoea Patient Reports February 12, 2012

Leuprolide Side Effects Report #5912430-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 29, 2008. Male patient, 94 years of age, was diagnosed with prostate cancer stage iv, thrombosis prophylaxis, pain  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyspnoea, oedema peripheral, pneumonia , protein total decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, ACETYLSALICYLIC ACID SRT, ETHINYL ESTRADIOL, FENTANYL. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5395634-4
Leuprolide side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure congestive, cardiomegaly, condition aggravated, dyspnoea, haemodialysis, heart rate irregular, oedema, oxygen saturation decreased. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEC, ARTIST, ALDACTONE, ACECOL, OMEPRAL, LOSARTAN POTASSIUM, FERROMIA, PURSENNID. Patient recovered.

Leuprolide Side Effects Report #5806244-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 30, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage iv, hypertension, diabetes mellitus, hyperlipidaemia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dyspnoea, metastases to lung, metastases to lymph nodes. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, CANDESARTAN CILEXETIL, VOGLIBOSE, BICALUTAMIDE, NATEGLINIDE, ETHYL ICOSAPENTATE. Patient died.

Leuprolide Side Effects Report #5818888-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 15, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage iv, hypertension, diabetes mellitus, hyperlipidaemia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dyspnoea, metastases to lung, metastases to lymph nodes. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, CANDESARTAN CILEXETIL, VOGLIBOSE, BICALUTAMIDE, NATEGLINIDE, ETHYL ICOSAPENTATE. Patient died.


Leuprolide Side Effects Report #4942994-1
Leuprolide side effect was reported by a Health Professional from JAPAN on Mar 03, 2006. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, lymphocyte stimulation test positive. Leuprolide dosage: 11.25 MG. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX. Patient died.

Leuprolide Side Effects Report #5046833-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea, haemoptysis, interstitial lung disease, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, RESTREAM, EVIPROSTAT, ALESION, ZANTAC, LAXOBERON. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5159190-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2006. Male patient, 80 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, dialysis , dyspnoea, face oedema, hydronephrosis, oedema peripheral, renal failure, tremor. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient recovered.

Leuprolide Side Effects Report #5170563-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 29, 2006. Male patient, 80 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dialysis , dyspnoea, hydronephrosis, postrenal failure, tremor. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient recovered.

Leuprolide Side Effects Report #4650408-4
Leuprolide side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Male patient, 80 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dyspnoea, nephrotic syndrome. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient was hospitalized and became disabled. Patient recovered.


Leuprolide Side Effects Report #5640450-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 20, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, computerised tomogram abnormal, cough, dyspnoea, interstitial lung disease, malaise, pneumocystis jiroveci pneumonia, productive cough, pseudomonas infection. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASTAREL F, LOXONIN. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5679874-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 19, 2008. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, cell marker increased, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, metastases to lung, pneumothorax. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5179050-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: crepitations, dyspnoea, interstitial lung disease, pneumothorax, rales. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4950816-8
Leuprolide side effect was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, 32 years of age, weighting 103.6 lb, was diagnosed with infertility , ovulation induction, assisted fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal pain , blood sodium decreased, dyspnoea, jugular vein thrombosis, ovarian hyperstimulation syndrome, platelet count increased, protein s abnormal, subclavian vein thrombosis. Leuprolide dosage: unknown. During the same period patient was treated with PROGESTERONE, PREGNYL, ORAL CONTRACEPTIVES NOS, UROFOLLITROPIN, MENOTROPINS. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5179016-6
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Dec 05, 2006. Female patient, 38 years of age, was diagnosed with in vitro fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, dyspnoea, pleural effusion. Leuprolide dosage: 1.87 MG (1.87 MG, 1 IN 1 DOSE). During the same period patient was treated with GONAL, GONADOTROPHIN CHRORIONIC, UTROGESTAN. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #5197697-8
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on Dec 22, 2006. Female patient, 38 years of age, was diagnosed with in vitro fertilisation and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: ascites, dyspnoea, ovarian hyperstimulation syndrome, pleural effusion. Leuprolide dosage: 1.87 MG (1.87 MG, 1 IN 1 ONCE), SUBCUTANEOUS/DAYS. During the same period patient was treated with GONAL, GONADOTROPHIN CHRORIONIC, UTROGESTAN. Patient recovered.

Leuprolide Side Effects Report #4698020-5
Leuprolide side effect was reported by a Consumer or non-health professional from on June 13, 2005. Female patient, 73 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, back pain , diastolic dysfunction, dilatation atrial, dyspnoea, glycosylated haemoglobin increased, mitral valve stenosis, ventricular hypertrophy. Leuprolide dosage: 22.5 MG (22.5 MG 1 IN 3 M) INTRAMUSCULAR. During the same period patient was treated with COLOXYL WITH SENNA, SIMVASTATIN, METFORMIN, GLICLAZIDE, RAMIPRIL, ISOSORBIDE MONONITRATE, ASPIRIN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5513398-8
Leuprolide side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Female patient, weighting 200.6 lb, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood cholesterol increased, chest discomfort, dyspnoea, glucose tolerance impaired. Leuprolide dosage: unknown. During the same period patient was treated with ZELNORM, RHINOCORT, WELLBUTRIN, NEXIUM. Patient recovered.